| scholarly article | Q13442814 |
| P2093 | author name string | Ming Li | |
| Wei Li | |||
| Feng Gao | |||
| Qing Zhao | |||
| Wenbin Liu | |||
| Huilan Zuo | |||
| P2860 | cites work | Repression of Hexokinases II-Mediated Glycolysis Contributes to Piperlongumine-Induced Tumor Suppression in Non-Small Cell Lung Cancer Cells | Q64078679 |
| Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity | Q90018202 | ||
| Tumor depth of invasion and prognosis of early-stage oral squamous cell carcinoma: A meta-analysis | Q90104329 | ||
| Long non‑coding RNA urothelial cancer associated 1 regulates radioresistance via the hexokinase 2/glycolytic pathway in cervical cancer | Q90278225 | ||
| Deguelin attenuates non-small cell lung cancer cell metastasis through inhibiting the CtsZ/FAK signaling pathway | Q90291830 | ||
| Tobacco and oral squamous cell carcinoma: A review of carcinogenic pathways | Q90468932 | ||
| Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis | Q90599381 | ||
| Cancer statistics, 2019 | Q90941571 | ||
| The immunoregulatory protein B7-H3 promotes aerobic glycolysis in oral squamous carcinoma via PI3K/Akt/mTOR pathway | Q91317461 | ||
| Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: Systematic review and meta-analysis | Q91370866 | ||
| Oral Cancer: Genetics and the Role of Precision Medicine | Q91401539 | ||
| Lymph node ratio as prognostic variable in oral squamous cell carcinomas: Systematic review and meta-analysis | Q91407541 | ||
| Cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth | Q91733324 | ||
| Tanshinone IIA Reverses Gefitinib-Resistance In Human Non-Small-Cell Lung Cancer Via Regulation Of VEGFR/Akt Pathway | Q91737684 | ||
| Opposite Effects of Garcinol on Tumor Energy Metabolism in Oral Squamous Cell Carcinoma Cells | Q91912939 | ||
| Tanshinone IIA enhances the inhibitory effect of imatinib on proliferation and motility of acute leukemia cell line TIB‑152 in vivo and in vitro by inhibiting the PI3K/AKT/mTOR signaling pathway | Q92366908 | ||
| The Influence of Met Receptor Level on HGF-Induced Glycolytic Reprogramming in Head and Neck Squamous Cell Carcinoma | Q92661565 | ||
| Hexokinase 2 dimerization and interaction with voltage-dependent anion channel promoted resistance to cell apoptosis induced by gemcitabine in pancreatic cancer | Q92700885 | ||
| Skp2-mediated ubiquitination and mitochondrial localization of Akt drive tumor growth and chemoresistance to cisplatin | Q92757921 | ||
| Effects and Mechanism of Tanshinone II A in Proliferation, Apoptosis, and Migration of Human Colon Cancer Cells | Q93098059 | ||
| Tanshinone IIA inhibits glucose metabolism leading to apoptosis in cervical cancer | Q93111153 | ||
| Hallmarks of Cancer: The Next Generation | Q22252312 | ||
| Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma | Q28072714 | ||
| Aerobic glycolysis: meeting the metabolic requirements of cell proliferation | Q29615178 | ||
| Poor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis | Q30234765 | ||
| Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis | Q33779169 | ||
| Targeting MCL-1 sensitizes human esophageal squamous cell carcinoma cells to cisplatin-induced apoptosis | Q33851111 | ||
| Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function | Q33966115 | ||
| Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. | Q34554825 | ||
| Histological and molecular aspects of oral squamous cell carcinoma (Review) | Q34662689 | ||
| Hexokinase II integrates energy metabolism and cellular protection: Akting on mitochondria and TORCing to autophagy | Q34924245 | ||
| Overexpression of pyruvate kinase M2 associates with aggressive clinicopathological features and unfavorable prognosis in oral squamous cell carcinoma | Q36213166 | ||
| Betel nut chewing, oral premalignant lesions, and the oral microbiome | Q36287412 | ||
| Tanshinones: sources, pharmacokinetics and anti-cancer activities | Q36396623 | ||
| MYC-induced cancer cell energy metabolism and therapeutic opportunities | Q37438881 | ||
| EZH2-mediated Puma gene repression regulates non-small cell lung cancer cell proliferation and cisplatin-induced apoptosis | Q37636628 | ||
| EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect | Q37706017 | ||
| Hexokinase 2 enhances the metastatic potential of tongue squamous cell carcinoma via the SOD2-H2O2 pathway | Q37709470 | ||
| Resveratrol inhibits Hexokinases II mediated glycolysis in non-small cell lung cancer via targeting Akt signaling pathway | Q38732069 | ||
| MicroRNA-340 Mediates Metabolic Shift in Oral Squamous Cell Carcinoma by Targeting Glucose Transporter-1. | Q38821783 | ||
| Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization | Q40625392 | ||
| High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer | Q42098076 | ||
| Deguelin, an Aurora B Kinase Inhibitor, Exhibits Potent Anti-Tumor Effect in Human Esophageal Squamous Cell Carcinoma | Q45874344 | ||
| Hexokinase 2 (HK2), the tumor promoter in glioma, is downregulated by miR-218/Bmi1 pathway | Q47151726 | ||
| Overexpression of hypoxia-inducible factor and metabolic pathways: possible targets of cancer | Q47153258 | ||
| Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy | Q47298651 | ||
| Partial Substitution of Glucose with Xylitol Suppressed the Glycolysis and Selectively Inhibited the Proliferation of Oral Cancer Cells. | Q48057543 | ||
| Large Intergenic Non-coding RNA-RoR Inhibits Aerobic Glycolysis of Glioblastoma Cells via Akt Pathway. | Q52340921 | ||
| Knockdown of LncRNA-UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA-125a/hexokinase 2 pathway. | Q52583847 | ||
| Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells. | Q52720194 | ||
| Salvanic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K/AKT/HIF-1α signaling pathway. | Q54978483 | ||
| VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis. | Q55129102 | ||
| The anticancer mechanism investigation of Tanshinone II by pharmacological clustering in protein network | Q58101390 | ||
| Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma | Q58772889 | ||
| B7-H3 promotes aerobic glycolysis and chemoresistance in colorectal cancer cells by regulating HK2 | Q64070924 | ||
| P433 | issue | 5 | |
| P921 | main subject | oral squamous cell carcinoma | Q18553522 |
| P304 | page(s) | 381 | |
| P577 | publication date | 2020-05-18 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis | |
| P478 | volume | 11 |
Search more.